TBG Diagnostics Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.01 |
Market Cap |
AUD7.62 M |
Shares Outstanding |
217.59 M |
Public Float |
- |
Address |
101 Collins Street Melbourne Victoria (VIC) 3000 Australia |
Employees | - |
Website | http://www.tbgbio.com |
Updated | 07/08/2019 |
TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. |